Comparative pharmacokinetics of enrofloxacin, danofloxacin and marbofloxacin following intramuscular administration in sheep

被引:0
作者
Karademir, Umit [1 ]
Boyacioglu, Murat [1 ]
Kum, Cavit [1 ]
Sekkin, Selim [1 ]
机构
[1] Adnan Menderes Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Isikli Koyu, Aydin, Turkey
关键词
Enrofloxacin; Danofloxacin; Marbofloxacin; Pharmacokinetics; Sheep; MANNHEIMIA-HAEMOLYTICA; INTEGRATION; HEALTHY; CALVES; GOATS; DISPOSITION; EXUDATE; PLASMA;
D O I
10.1016/j.smallrumres.2015.09.007
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The aim of this study was to determine and compare the pharmacokinetic profiles of enrofloxacin (ENF), danofloxacin (DNF) and marbofloxacin (MBF) after intramuscular administration in sheep. A total of 18 cross-bred healthy sheep were used in the study. The animals were allocated into three groups of six such that the mean weight of animals in each group was similar. In Group I (ENF) was given intramuscularly at a dose rate of 2.5 mg/kg, in Group II (DNF) was given intramuscularly at a dose rate of 1.25 mg/kg and in Group III (MBF) was given intramuscularly at a dose rate of 2 mg/kg. Heparinized blood samples were collected between 0.5 and 48 h after treatment. The results indicated that MBF produced a significantly higher maximum plasma concentration (C-max:1.43 +/- 0.50 mu g/ml) with quicker absorption (t(max) : 1.00 +/- 0.00) and larger area under the concentration vs. time curve (AUC: 8.36 +/- 2.58 mu gh/ml) as compared with ENF (C-max: 0.88 +/- 0.13 mu g/ml, t(max): 1.66 +/- 0.47, AUC: 5.64 +/- 2.52 mu gh/ml) and DNF (C-max: 0.70 +/- 0.08 mu g/ml, t(max): 1.33 +/- 0.23, AUC: 3.00 +/- 0.65 mu g h/ml) following intramuscular administration of drugs. Similarly, the mean residence time (MRT: 6.37 +/- 0.59) and the half-life (t(1/2 lambda z): 9.50 +/- 1.86) was significantly longer MBF group than ENF(MRT: 4.54 +/- 0.79, t(1/2 lambda z): 3.06 +/- 0.39) and DNF (MRT: 4.04 +/- 0.17, t(1/2 lambda z): 3.52 +/- 0.22) groups. In this study, regarding ENF, DNF and MBF, three of fluoroquinolones antibacterial agents with common usages in sheep at recommended doses, with intramuscular administration were compared in pharmacokinetic parameters and as a result, marbofloxacin was found significantly the highest in rate to reach the maximum concentration in plasma. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 23 条
  • [1] Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids
    Aliabadi, FS
    Landoni, MF
    Lees, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 626 - 635
  • [2] Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate
    Aliabadi, FS
    Lees, P
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2002, 25 (03) : 161 - 174
  • [3] [Anonymous], 1998, GUIDANCE IND VALIDAT
  • [4] [Anonymous], 1999, GUIDANCE IND VALIDAT
  • [5] Some pharmacokinetic data for danofloxacin in healthy goats
    Atef M.
    El-Gendi A.Y.
    Aziza
    Amer M.M.
    Abd El-Aty A.M.
    [J]. Veterinary Research Communications, 2001, 25 (5) : 367 - 377
  • [6] Elmas M, 2001, CAN J VET RES, V65, P64
  • [7] Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits
    Elmas, Muammer
    Yazar, Enver
    Uney, Kamil
    Er , Ayse
    Tras, Buenyamin
    [J]. VETERINARY JOURNAL, 2008, 177 (03) : 418 - 424
  • [8] Pharmacokinetics of enrofloxacin in lactating sheep
    Haritova, A
    Lashev, L
    Pashov, D
    [J]. RESEARCH IN VETERINARY SCIENCE, 2003, 74 (03) : 241 - 245
  • [9] Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves
    Ismail, M.
    El-Kattan, Y. A.
    [J]. RESEARCH IN VETERINARY SCIENCE, 2007, 82 (03) : 398 - 404
  • [10] Pharmacokinetics of danofloxacin following intravenous and intramuscular administration in donkeys
    Kum, C.
    Gokbulut, C.
    Sekkin, S.
    Boyacioglu, M.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 (01) : 105 - 108